SIMILAR PATTERNS OF AMINO ACIDS FOR 2JKL_B_CLMB1144

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1a87 COLICIN N

(Escherichia
coli)
PF01024
(Colicin)
4 PRO A 101
PRO A 106
GLY A 107
TYR A 109
None
0.82A 2jklB-1a87A:
undetectable
2jklB-1a87A:
19.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1cg4 PROTEIN
(ADENYLOSUCCINATE
SYNTHETASE)


(Escherichia
coli)
PF00709
(Adenylsucc_synt)
4 GLY A 264
ILE A 410
GLY A 326
TYR A 261
None
0.86A 2jklB-1cg4A:
undetectable
2jklB-1cg4A:
17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1d4e FLAVOCYTOCHROME C
FUMARATE REDUCTASE


(Shewanella
oneidensis)
PF00890
(FAD_binding_2)
PF14537
(Cytochrom_c3_2)
4 PRO A 160
GLY A 134
ILE A 130
GLY A 132
None
FAD  A 600 (-3.1A)
None
FAD  A 600 (-3.4A)
0.78A 2jklB-1d4eA:
0.0
2jklB-1d4eA:
14.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1de4 HEMOCHROMATOSIS
PROTEIN


(Homo sapiens)
PF00129
(MHC_I)
PF07654
(C1-set)
4 PRO A 236
GLY A 238
GLY A 240
TYR A 242
None
0.64A 2jklB-1de4A:
0.0
2jklB-1de4A:
18.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1exc PROTEIN MAF

(Bacillus
subtilis)
PF02545
(Maf)
4 GLY A 154
ILE A 152
GLY A 156
TYR A 137
None
0.86A 2jklB-1excA:
undetectable
2jklB-1excA:
17.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)


(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.76A 2jklB-1forH:
0.0
2jklB-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fpt IGG2A-KAPPA C3 FAB
(HEAVY CHAIN)


(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY H  53
PRO H  52
ILE H  51
GLY H  55
None
0.80A 2jklB-1fptH:
1.3
2jklB-1fptH:
21.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1iaw TYPE II RESTRICTION
ENZYME NAEI


(Lechevalieria
aerocolonigenes)
PF09126
(NaeI)
4 PRO A 267
GLY A 270
ILE A 218
GLY A 214
None
0.83A 2jklB-1iawA:
0.0
2jklB-1iawA:
17.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jv5 IG CHAIN HEAVY CHAIN
PRECURSOR V REGION


(Homo sapiens)
PF07686
(V-set)
4 GLY B 354
PRO B 353
ILE B 351
GLY B 356
None
0.82A 2jklB-1jv5B:
0.0
2jklB-1jv5B:
20.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ko0 DIAMINOPIMELATE
DECARBOXYLASE


(Escherichia
coli)
PF00278
(Orn_DAP_Arg_deC)
PF02784
(Orn_Arg_deC_N)
4 GLY A 270
PRO A 269
ILE A 267
GLY A 226
PLP  A 540 (-3.3A)
None
None
PLP  A 540 (-3.6A)
0.79A 2jklB-1ko0A:
undetectable
2jklB-1ko0A:
18.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lbu MURAMOYL-PENTAPEPTID
E CARBOXYPEPTIDASE


(Streptomyces
albus)
PF01471
(PG_binding_1)
PF08291
(Peptidase_M15_3)
5 PRO A 190
GLY A 188
PRO A 209
ILE A 213
GLY A 186
None
1.26A 2jklB-1lbuA:
undetectable
2jklB-1lbuA:
23.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lqt FPRA

(Mycobacterium
tuberculosis)
PF07992
(Pyr_redox_2)
4 PRO A  45
GLY A  12
ILE A   8
GLY A  10
ACT  A1871 ( 4.1A)
FAD  A2457 (-3.6A)
None
FAD  A2457 (-3.2A)
0.83A 2jklB-1lqtA:
undetectable
2jklB-1lqtA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mex FAB 29G12 HEAVY
CHAIN


(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY H  53
PRO H  52
ILE H  51
GLY H  55
None
0.81A 2jklB-1mexH:
2.1
2jklB-1mexH:
19.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pls PLECKSTRIN HOMOLOGY
DOMAIN


(Homo sapiens)
PF00169
(PH)
4 PRO A  44
GLY A  46
ILE A  33
TYR A  36
None
0.82A 2jklB-1plsA:
undetectable
2jklB-1plsA:
18.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q0y FAB 9B1, HEAVY CHAIN

(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY H  53
PRO H  52
ILE H  51
GLY H  55
None
0.84A 2jklB-1q0yH:
undetectable
2jklB-1q0yH:
20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qr7 PHENYLALANINE-REGULA
TED
3-DEOXY-D-ARABINO-HE
PTULOSONATE-7-PHOSPH
ATE SYNTHASE


(Escherichia
coli)
PF00793
(DAHP_synth_1)
4 PRO A 182
GLY A 160
ILE A 232
GLY A 184
None
0.86A 2jklB-1qr7A:
undetectable
2jklB-1qr7A:
16.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rvf FAB 17-IA

(Mus musculus)
PF07686
(V-set)
4 GLY H  53
PRO H  52
ILE H  51
GLY H  55
None
0.75A 2jklB-1rvfH:
undetectable
2jklB-1rvfH:
18.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1umg 385AA LONG CONSERVED
HYPOTHETICAL PROTEIN


(Sulfurisphaera
tokodaii)
PF01950
(FBPase_3)
4 GLY A 110
PRO A 111
ILE A   9
GLY A 112
None
0.82A 2jklB-1umgA:
undetectable
2jklB-1umgA:
15.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ut1 DR HEMAGGLUTININ
STRUCTURAL SUBUNIT


(Escherichia
coli)
PF04619
(Adhesin_Dr)
6 PRO A  40
GLY A  42
PRO A  43
ILE A 111
GLY A 113
TYR A 115
EDO  A1143 ( 4.3A)
None
None
None
None
None
0.49A 2jklB-1ut1A:
27.4
2jklB-1ut1A:
99.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yed IGG1 FAB FRAGMENT
(D.2.4)


(Mus musculus)
no annotation 4 GLY H  53
PRO H  52
ILE H  51
GLY H  55
None
0.85A 2jklB-1yedH:
undetectable
2jklB-1yedH:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ae0 MEMBRANE-BOUND LYTIC
MUREIN
TRANSGLYCOSYLASE A


(Escherichia
coli)
PF03562
(MltA)
PF06725
(3D)
5 PRO X 104
GLY X 314
PRO X 315
GLY X 318
TYR X 102
None
1.05A 2jklB-2ae0X:
undetectable
2jklB-2ae0X:
16.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cqv MYOSIN LIGHT CHAIN
KINASE, SMOOTH
MUSCLE AND
NON-MUSCLE ISOZYMES


(Homo sapiens)
PF07679
(I-set)
4 GLY A   7
PRO A   8
ILE A  37
GLY A  33
None
0.78A 2jklB-2cqvA:
undetectable
2jklB-2cqvA:
22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2czt PROSTAGLANDIN-H2
D-ISOMERASE


(Mus musculus)
PF00061
(Lipocalin)
4 PRO A  98
PRO A 102
GLY A 103
TYR A 105
None
0.59A 2jklB-2cztA:
undetectable
2jklB-2cztA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2e27 ANTI-CIGUATOXIN
ANTIBODY, HEAVY
CHAIN


(Mus musculus)
PF07686
(V-set)
4 GLY H  53
PRO H 521
ILE H  51
GLY H  55
None
0.85A 2jklB-2e27H:
undetectable
2jklB-2e27H:
22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eyq TRANSCRIPTION-REPAIR
COUPLING FACTOR


(Escherichia
coli)
PF00270
(DEAD)
PF00271
(Helicase_C)
PF02559
(CarD_CdnL_TRCF)
PF03461
(TRCF)
4 PRO A 522
ILE A 504
GLY A 506
TYR A 508
None
0.60A 2jklB-2eyqA:
undetectable
2jklB-2eyqA:
10.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gp4 6-PHOSPHOGLUCONATE
DEHYDRATASE


(Shewanella
oneidensis)
PF00920
(ILVD_EDD)
4 PRO A 177
GLY A 179
PRO A 180
ILE A 344
None
0.80A 2jklB-2gp4A:
undetectable
2jklB-2gp4A:
14.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jis CYSTEINE SULFINIC
ACID DECARBOXYLASE


(Homo sapiens)
PF00282
(Pyridoxal_deC)
4 PRO A  87
GLY A  85
ILE A  33
GLY A  36
None
0.79A 2jklB-2jisA:
undetectable
2jklB-2jisA:
14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pb7 E3 UBIQUITIN-PROTEIN
LIGASE UHRF1


(Homo sapiens)
PF02182
(SAD_SRA)
4 GLY A 588
PRO A 589
ILE A 598
GLY A 594
None
0.53A 2jklB-2pb7A:
undetectable
2jklB-2pb7A:
20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pff FATTY ACID SYNTHASE
SUBUNIT ALPHA


(Saccharomyces
cerevisiae)
PF00106
(adh_short)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
4 PRO A1071
GLY A1069
GLY A1074
TYR A1072
None
0.75A 2jklB-2pffA:
undetectable
2jklB-2pffA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pnc COPPER AMINE
OXIDASE, LIVER
ISOZYME


(Bos taurus)
PF01179
(Cu_amine_oxid)
PF02727
(Cu_amine_oxidN2)
PF02728
(Cu_amine_oxidN3)
4 PRO A 241
GLY A 243
GLY A 227
TYR A 229
None
0.67A 2jklB-2pncA:
undetectable
2jklB-2pncA:
11.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q1f CHONDROITINASE

(Bacteroides
thetaiotaomicron)
PF02278
(Lyase_8)
PF09092
(Lyase_N)
PF09093
(Lyase_catalyt)
4 GLY A 853
PRO A 852
ILE A 850
GLY A 800
None
0.86A 2jklB-2q1fA:
undetectable
2jklB-2q1fA:
9.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qmw PREPHENATE
DEHYDRATASE


(Staphylococcus
aureus)
PF00800
(PDT)
5 PRO A  30
GLY A   7
PRO A   8
ILE A 129
GLY A  10
None
1.42A 2jklB-2qmwA:
undetectable
2jklB-2qmwA:
18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r4s ANTIBODY FOR BETA2
ADRENOCEPTOR, HEAVY
CHAIN


(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.74A 2jklB-2r4sH:
undetectable
2jklB-2r4sH:
19.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ri6 2-HYDROXY-6-OXO-6-PH
ENYLHEXA-2,4-DIENOAT
E HYDROLASE


(Paraburkholderia
xenovorans)
PF12697
(Abhydrolase_6)
4 GLY A  43
PRO A  44
ILE A 194
GLY A  45
MLI  A   2 (-3.5A)
None
None
None
0.77A 2jklB-2ri6A:
undetectable
2jklB-2ri6A:
19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vtc CEL61B

(Trichoderma
reesei)
PF03443
(Glyco_hydro_61)
4 GLY A  92
PRO A  93
ILE A 222
GLY A 122
None
0.86A 2jklB-2vtcA:
undetectable
2jklB-2vtcA:
21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vwe ANTI-VEGF-B
MONOCLONAL ANTIBODY


(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY E  53
PRO E  52
ILE E  51
GLY E  55
None
0.80A 2jklB-2vweE:
undetectable
2jklB-2vweE:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wok CLAVULANIC ACID
BIOSYNTHESIS
OLIGOPEPTIDE BINDING
PROTEIN 2


(Streptomyces
clavuligerus)
PF00496
(SBP_bac_5)
4 GLY A  88
PRO A  89
GLY A  90
TYR A 101
None
0.84A 2jklB-2wokA:
0.4
2jklB-2wokA:
13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y05 PROSTAGLANDIN
REDUCTASE 1


(Homo sapiens)
PF00107
(ADH_zinc_N)
PF16884
(ADH_N_2)
4 PRO A 252
GLY A 254
PRO A 255
ILE A 227
None
0.68A 2jklB-2y05A:
undetectable
2jklB-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y27 PHENYLACETATE-COENZY
ME A LIGASE


(Burkholderia
cenocepacia)
PF00501
(AMP-binding)
PF14535
(AMP-binding_C_2)
4 GLY A 244
PRO A 245
ILE A 236
GLY A 238
GOL  A 505 (-3.9A)
GOL  A 505 (-3.7A)
GOL  A 505 ( 4.5A)
GOL  A 505 ( 3.4A)
0.82A 2jklB-2y27A:
undetectable
2jklB-2y27A:
16.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y4o PHENYLACETATE-COENZY
ME A LIGASE


(Burkholderia
cenocepacia)
PF00501
(AMP-binding)
PF14535
(AMP-binding_C_2)
4 GLY A 248
PRO A 249
ILE A 240
GLY A 242
DLL  A1441 ( 4.4A)
DLL  A1441 ( 4.0A)
DLL  A1441 (-4.7A)
DLL  A1441 (-4.1A)
0.77A 2jklB-2y4oA:
undetectable
2jklB-2y4oA:
16.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ydy METHIONINE
ADENOSYLTRANSFERASE
2 SUBUNIT BETA


(Homo sapiens)
PF04321
(RmlD_sub_bind)
5 PRO A 221
PRO A 310
ILE A 313
GLY A 314
TYR A 186
None
1.44A 2jklB-2ydyA:
undetectable
2jklB-2ydyA:
18.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yxe PROTEIN-L-ISOASPARTA
TE
O-METHYLTRANSFERASE


(Methanocaldococcus
jannaschii)
PF01135
(PCMT)
4 PRO A 206
GLY A 156
PRO A 157
GLY A 178
None
0.74A 2jklB-2yxeA:
undetectable
2jklB-2yxeA:
20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z4q ANTI EGFR ANTIBODY
FAB, HEAVY CHAIN


(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY B  54
PRO B  53
ILE B  51
GLY B  56
None
0.80A 2jklB-2z4qB:
undetectable
2jklB-2z4qB:
21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zki 199AA LONG
HYPOTHETICAL TRP
REPRESSOR BINDING
PROTEIN


(Sulfurisphaera
tokodaii)
PF03358
(FMN_red)
4 PRO A 143
GLY A 145
PRO A 160
GLY A 162
None
0.87A 2jklB-2zkiA:
undetectable
2jklB-2zkiA:
20.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a9g PUTATIVE
UNCHARACTERIZED
PROTEIN


(Pyrobaculum
aerophilum)
PF07995
(GSDH)
4 PRO A  53
GLY A  55
GLY A  57
TYR A  59
None
0.51A 2jklB-3a9gA:
undetectable
2jklB-3a9gA:
17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bdi UNCHARACTERIZED
PROTEIN TA0194


(Thermoplasma
acidophilum)
PF00561
(Abhydrolase_1)
PF12146
(Hydrolase_4)
4 PRO A 132
GLY A 111
ILE A 103
GLY A 105
None
0.82A 2jklB-3bdiA:
undetectable
2jklB-3bdiA:
22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dwh E3 UBIQUITIN-PROTEIN
LIGASE UHRF1


(Homo sapiens)
PF02182
(SAD_SRA)
4 GLY A 588
PRO A 589
ILE A 598
GLY A 594
None
0.69A 2jklB-3dwhA:
undetectable
2jklB-3dwhA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3f8r THIOREDOXIN
REDUCTASE (TRXB-3)


(Sulfolobus
solfataricus)
PF07992
(Pyr_redox_2)
4 PRO A  48
GLY A  24
ILE A  20
GLY A  22
None
NAP  A4005 (-3.3A)
None
NAP  A4005 (-3.1A)
0.83A 2jklB-3f8rA:
undetectable
2jklB-3f8rA:
20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iuu PUTATIVE
METALLOPEPTIDASE


(Chelativorans
sp. BNC1)
PF07171
(MlrC_C)
PF07364
(DUF1485)
4 GLY A 307
PRO A 308
ILE A  21
GLY A  72
None
0.82A 2jklB-3iuuA:
undetectable
2jklB-3iuuA:
14.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j8v H16.14J HEAVY CHAIN

(Mus musculus)
no annotation 4 GLY H  53
PRO H  52
ILE H  51
GLY H  55
None
0.86A 2jklB-3j8vH:
undetectable
2jklB-3j8vH:
19.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j8w H263.A2 HEAVY CHAIN

(Mus musculus)
no annotation 4 GLY H  53
PRO H  52
ILE H  51
GLY H  55
None
0.84A 2jklB-3j8wH:
undetectable
2jklB-3j8wH:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j8z H16.1A HEAVY CHAIN

(Mus musculus)
no annotation 4 GLY H  53
PRO H  52
ILE H  51
GLY H  55
None
0.81A 2jklB-3j8zH:
undetectable
2jklB-3j8zH:
22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nwr A RUBISCO-LIKE
PROTEIN


(Paraburkholderia
fungorum)
PF00016
(RuBisCO_large)
PF02788
(RuBisCO_large_N)
5 PRO A 388
GLY A 390
PRO A 391
ILE A 384
GLY A 394
None
1.25A 2jklB-3nwrA:
undetectable
2jklB-3nwrA:
15.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nz8 MOUSE ANTI V3
ANTIBODY 7C8 FAB,
HEAVY CHAIN


(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY A  53
PRO A  52
ILE A  51
GLY A  55
None
0.84A 2jklB-3nz8A:
undetectable
2jklB-3nz8A:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o2y PROSTAGLANDIN-H2
D-ISOMERASE


(Homo sapiens)
PF00061
(Lipocalin)
4 PRO A  98
GLY A 100
GLY A 103
TYR A 105
None
0.86A 2jklB-3o2yA:
undetectable
2jklB-3o2yA:
22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ps9 TRNA
5-METHYLAMINOMETHYL-
2-THIOURIDINE
BIOSYNTHESIS
BIFUNCTIONAL PROTEIN
MNMC


(Escherichia
coli)
PF01266
(DAO)
PF05430
(Methyltransf_30)
4 PRO A 299
GLY A 273
ILE A 269
GLY A 271
None
FAD  A 669 (-3.3A)
None
FAD  A 669 (-3.5A)
0.69A 2jklB-3ps9A:
undetectable
2jklB-3ps9A:
12.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pvc TRNA
5-METHYLAMINOMETHYL-
2-THIOURIDINE
BIOSYNTHESIS
BIFUNCTIONAL PROTEIN
MNMC


(Yersinia pestis)
PF01266
(DAO)
PF05430
(Methyltransf_30)
4 PRO A 299
GLY A 273
ILE A 269
GLY A 271
None
FAD  A 690 (-3.3A)
None
FAD  A 690 (-3.3A)
0.79A 2jklB-3pvcA:
undetectable
2jklB-3pvcA:
12.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rcn BETA-N-ACETYLHEXOSAM
INIDASE


(Paenarthrobacter
aurescens)
PF00728
(Glyco_hydro_20)
PF02838
(Glyco_hydro_20b)
4 PRO A 399
GLY A 381
ILE A 386
GLY A 385
None
0.83A 2jklB-3rcnA:
undetectable
2jklB-3rcnA:
13.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rh9 SUCCINATE-SEMIALDEHY
DE DEHYDROGENASE
(NAD(P)(+))


(Marinobacter
hydrocarbonoclasticus)
PF00171
(Aldedh)
4 GLY A 389
PRO A 390
ILE A 327
GLY A 284
None
0.74A 2jklB-3rh9A:
undetectable
2jklB-3rh9A:
14.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t3o METAL DEPENDENT
HYDROLASE


(Thermus
thermophilus)
PF07521
(RMMBL)
PF12706
(Lactamase_B_2)
4 GLY A 360
PRO A 331
GLY A 332
TYR A 362
None
0.86A 2jklB-3t3oA:
undetectable
2jklB-3t3oA:
12.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tt1 MOUSE MONOCLONAL
1GG2A FAB FRAGMENT,
KAPPA LIGHT CHAIN


(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.86A 2jklB-3tt1H:
undetectable
2jklB-3tt1H:
20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v76 FLAVOPROTEIN

(Sinorhizobium
meliloti)
PF03486
(HI0933_like)
4 PRO A  40
GLY A  14
ILE A  10
GLY A  12
None
FDA  A 547 (-3.4A)
None
FDA  A 547 (-3.4A)
0.79A 2jklB-3v76A:
undetectable
2jklB-3v76A:
18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ala FAB 2H12 HEAVY CHAIN

(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.82A 2jklB-4alaH:
2.3
2jklB-4alaH:
20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4cmh HEAVY CHAIN OF
SAR650984-FAB
FRAGMENT


(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY B  54
PRO B  53
ILE B  51
GLY B  56
None
0.86A 2jklB-4cmhB:
undetectable
2jklB-4cmhB:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4d7u ENDOGLUCANASE II

(Neurospora
crassa)
PF03443
(Glyco_hydro_61)
4 GLY A  85
PRO A  86
ILE A 219
GLY A 114
None
0.84A 2jklB-4d7uA:
undetectable
2jklB-4d7uA:
20.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e4u MANDALATE
RACEMASE/MUCONATE
LACTONIZING ENZYME


(unidentified)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
4 GLY A 313
PRO A 314
ILE A 368
GLY A 316
None
0.83A 2jklB-4e4uA:
undetectable
2jklB-4e4uA:
17.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4eis POLYSACCHARIDE
MONOOXYGENASE-3


(Neurospora
crassa)
PF03443
(Glyco_hydro_61)
4 GLY B  84
PRO B  85
ILE B 217
GLY B 117
None
0.85A 2jklB-4eisB:
undetectable
2jklB-4eisB:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fj4 UNCHARACTERIZED
PROTEIN


(Halobacterium
salinarum)
PF07920
(DUF1684)
4 PRO A 138
GLY A 140
GLY A 144
TYR A  64
None
0.85A 2jklB-4fj4A:
undetectable
2jklB-4fj4A:
21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gmk RIBOSE-5-PHOSPHATE
ISOMERASE A


(Lactobacillus
salivarius)
PF06026
(Rib_5-P_isom_A)
4 GLY A 220
PRO A 221
ILE A 214
GLY A 216
None
0.63A 2jklB-4gmkA:
undetectable
2jklB-4gmkA:
19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kaq RITUXIMAB HEAVY
CHAIN


(Homo sapiens;
Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.80A 2jklB-4kaqH:
undetectable
2jklB-4kaqH:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ki5 MURINE MONOCLONAL
G99 FAB HEAVY CHAIN


(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY E  54
PRO E  53
ILE E  51
GLY E  56
GLY  E  54 ( 0.0A)
PRO  E  53 ( 1.1A)
ILE  E  51 ( 0.7A)
GLY  E  56 ( 0.0A)
0.83A 2jklB-4ki5E:
undetectable
2jklB-4ki5E:
20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kuc MAB6C2 FAB-LIGHT
CHAIN


(Mus musculus)
no annotation 4 GLY H  73
PRO H  72
ILE H  70
GLY H  75
None
0.79A 2jklB-4kucH:
undetectable
2jklB-4kucH:
21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lcc BETA-2-MICROGLOBULIN
, MHC CLASS
I-RELATED PROTEIN


(Bos taurus)
PF00129
(MHC_I)
PF07654
(C1-set)
4 PRO C 345
GLY C 347
GLY C 349
TYR C 351
None
0.75A 2jklB-4lccC:
undetectable
2jklB-4lccC:
16.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mo9 PERIPLASMIC BINDING
PROTEIN


(Veillonella
parvula)
PF01497
(Peripla_BP_2)
4 GLY A  47
PRO A  48
ILE A  52
TYR A 146
None
0.86A 2jklB-4mo9A:
undetectable
2jklB-4mo9A:
18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mt1 DRUG EFFLUX PROTEIN

(Neisseria
gonorrhoeae)
PF00873
(ACR_tran)
4 GLY A  51
PRO A  50
ILE A  48
GLY A  86
None
0.80A 2jklB-4mt1A:
undetectable
2jklB-4mt1A:
8.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mx8 PERIPLASMIC BINDING
PROTEIN


(Xylanimonas
cellulosilytica)
PF01497
(Peripla_BP_2)
5 PRO A 218
GLY A 181
ILE A 184
GLY A 183
TYR A 211
None
1.30A 2jklB-4mx8A:
undetectable
2jklB-4mx8A:
18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4n5f PUTATIVE ACYL-COA
DEHYDROGENASE


(Burkholderia
cenocepacia)
PF00441
(Acyl-CoA_dh_1)
PF02770
(Acyl-CoA_dh_M)
PF02771
(Acyl-CoA_dh_N)
4 GLY A  96
PRO A  97
ILE A 234
GLY A 100
None
0.78A 2jklB-4n5fA:
undetectable
2jklB-4n5fA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nqe MAJOR
HISTOCOMPATIBILITY
COMPLEX CLASS
I-RELATED GENE
PROTEIN


(Homo sapiens)
PF00129
(MHC_I)
PF07654
(C1-set)
4 PRO A 232
GLY A 234
GLY A 236
TYR A 238
None
0.83A 2jklB-4nqeA:
undetectable
2jklB-4nqeA:
19.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nsx U3 SMALL NUCLEOLAR
RNA-ASSOCIATED
PROTEIN 21


(Saccharomyces
cerevisiae)
PF00400
(WD40)
PF12894
(ANAPC4_WD40)
4 GLY A 538
ILE A 525
GLY A 527
TYR A 529
None
0.61A 2jklB-4nsxA:
undetectable
2jklB-4nsxA:
13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ol9 PUTATIVE
2-DEHYDROPANTOATE
2-REDUCTASE


(Mycobacterium
tuberculosis)
PF02558
(ApbA)
PF08546
(ApbA_C)
4 GLY A   9
PRO A  10
ILE A  39
GLY A  14
NAP  A 301 (-3.3A)
ACT  A 303 ( 3.4A)
None
None
0.70A 2jklB-4ol9A:
undetectable
2jklB-4ol9A:
17.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xb3 GLUCAN
1,6-ALPHA-GLUCOSIDAS
E


(Streptococcus
mutans)
PF00128
(Alpha-amylase)
PF16657
(Malt_amylase_C)
4 PRO A 212
ILE A 202
GLY A 200
TYR A 217
None
0.85A 2jklB-4xb3A:
undetectable
2jklB-4xb3A:
13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yke MRE11

(Chaetomium
thermophilum)
PF00149
(Metallophos)
PF04152
(Mre11_DNA_bind)
4 GLY A 263
PRO A 262
ILE A 238
GLY A 240
None
0.84A 2jklB-4ykeA:
undetectable
2jklB-4ykeA:
12.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zfq L,D-TRANSPEPTIDASE 5

(Mycobacterium
tuberculosis)
PF03734
(YkuD)
4 PRO A 242
GLY A 244
GLY A 246
TYR A 248
None
0.69A 2jklB-4zfqA:
undetectable
2jklB-4zfqA:
16.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cma ANTIBODY CH8H9 FAB
HEAVY CHAIN


(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY B  54
PRO B  53
ILE B  51
GLY B  56
None
0.80A 2jklB-5cmaB:
undetectable
2jklB-5cmaB:
19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d1p ATP-DEPENDENT RNA
LIGASE


(Methanothermobacter
thermautotrophicus)
PF09414
(RNA_ligase)
4 PRO A 165
GLY A 168
PRO A 169
GLY A 154
None
0.84A 2jklB-5d1pA:
undetectable
2jklB-5d1pA:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eb5 HNL ISOENZYME 5

(Prunus dulcis)
PF00732
(GMC_oxred_N)
PF05199
(GMC_oxred_C)
4 PRO A 288
GLY A 273
ILE A 283
GLY A 271
None
0.84A 2jklB-5eb5A:
undetectable
2jklB-5eb5A:
15.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f3j ANTIBODY 2D10 SINGLE
CHAIN VARIABLE
FRAGMENT


(Mus musculus)
PF07686
(V-set)
4 GLY C 223
PRO C 222
ILE C 220
GLY C 225
None
0.86A 2jklB-5f3jC:
undetectable
2jklB-5f3jC:
14.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g56 CARBOHYDRATE BINDING
FAMILY 6


(Ruminiclostridium
thermocellum)
PF00150
(Cellulase)
PF03422
(CBM_6)
4 PRO A 515
GLY A 566
GLY A 441
TYR A 443
None
0.83A 2jklB-5g56A:
1.7
2jklB-5g56A:
10.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g56 CARBOHYDRATE BINDING
FAMILY 6


(Ruminiclostridium
thermocellum)
PF00150
(Cellulase)
PF03422
(CBM_6)
4 PRO A 604
GLY A 606
GLY A 608
TYR A 610
None
0.79A 2jklB-5g56A:
1.7
2jklB-5g56A:
10.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iz1 FRUCTOSE-1,6-BISPHOS
PHATASE


(Physcomitrella
patens)
PF00316
(FBPase)
5 PRO A 248
PRO A 376
ILE A 214
GLY A 216
TYR A 218
None
1.43A 2jklB-5iz1A:
undetectable
2jklB-5iz1A:
17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j44 SERINE PROTEASE SEPA
AUTOTRANSPORTER


(Shigella
flexneri)
PF02395
(Peptidase_S6)
4 PRO A 197
GLY A 200
PRO A 201
ILE A  31
None
0.84A 2jklB-5j44A:
undetectable
2jklB-5j44A:
9.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jm6 AMINOPEPTIDASE-LIKE
PROTEIN


(Chaetomium
thermophilum)
PF02127
(Peptidase_M18)
5 PRO A  51
GLY A 497
PRO A 496
ILE A 479
GLY A 499
None
1.40A 2jklB-5jm6A:
undetectable
2jklB-5jm6A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kvd ZV-2 ANTIBODY FAB
HEAVY CHAIN


(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY H  53
PRO H  52
ILE H  51
GLY H  55
None
0.86A 2jklB-5kvdH:
undetectable
2jklB-5kvdH:
21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mjk THIOREDOXIN
REDUCTASE


(Lactococcus
lactis)
PF07992
(Pyr_redox_2)
4 PRO A  39
GLY A  14
ILE A  10
GLY A  12
None
FAD  A 401 (-3.3A)
None
FAD  A 401 (-3.3A)
0.85A 2jklB-5mjkA:
undetectable
2jklB-5mjkA:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5myx FAB C#24 HEAVY CHAIN

(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY B  54
PRO B  53
ILE B  51
GLY B  56
None
0.86A 2jklB-5myxB:
undetectable
2jklB-5myxB:
21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nlt CVAA9A

(Collariella
virescens)
no annotation 4 GLY A  81
PRO A  82
ILE A 216
GLY A 109
None
0.84A 2jklB-5nltA:
undetectable
2jklB-5nltA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ufv GLYCOSIDE HYDROLASE
FAMILY 61 PROTEIN


(Thermothelomyces
thermophila)
PF03443
(Glyco_hydro_61)
4 GLY A  78
PRO A  79
ILE A 219
GLY A 108
None
0.75A 2jklB-5ufvA:
undetectable
2jklB-5ufvA:
19.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uwy THIOREDOXIN
REDUCTASE


(Streptococcus
pyogenes)
PF07992
(Pyr_redox_2)
4 PRO A  35
GLY A  10
ILE A   6
GLY A   8
None
FAD  A 401 (-3.3A)
None
FAD  A 401 ( 3.8A)
0.85A 2jklB-5uwyA:
undetectable
2jklB-5uwyA:
19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5w5x 3C10 FAB' HEAVY
CHAIN


(Rattus
norvegicus)
no annotation 4 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.86A 2jklB-5w5xH:
undetectable
2jklB-5w5xH:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bs7 ADENYLOSUCCINATE
SYNTHETASE


(Legionella
pneumophila)
no annotation 4 GLY A 265
ILE A 411
GLY A 327
TYR A 262
None
0.87A 2jklB-6bs7A:
undetectable
2jklB-6bs7A:
undetectable